Patrick O'Brien
Chief Operating Officer, See Remarks, Greenlight Capital Re, Ltd.; COO, Arrowhead Pharmaceuticals
Bought, 12 months
$0.0M
Sold, 12 months
$3.2M
Companies
2
Latest trade
Jun 23, 2026
Companies
Greenlight Capital Re, Ltd.Chief Operating Officer, See Remarks −$0.0M Arrowhead PharmaceuticalsCOO −$3.1MTrades
Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.

